Inventor · disambiguated record
Wei Wu
Also filed as: WU WEI · WU WEI-SHEN
7 granted patents·5 pending applications·19 citations·filing 2011–2024
82Inventor score
Top patents by PatentIndex Score
12 records- 0193US12227557B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2022·Granted Feb 18, 2025·2 cites·20 claims
- 0286US11261233B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2017·Granted Mar 1, 2022·6 cites·19 claims
- 0382US10793617B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2018·Granted Oct 6, 2020·1 cites·14 claims
- 0482US9611309B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2014·Granted Apr 4, 2017·2 cites·17 claims
- 0581US8895022B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2013·Granted Nov 25, 2014·2 cites·9 claims
- 0677US8808697B2Methods of use of soluble CD24 for therapy of rheumatoid arthritisZHENG XINCHENG·Filed 2011·Granted Aug 19, 2014·6 cites·6 claims
- 0776US12441780B2CD80 and CD86 binding protein compositions and uses thereofONCOC4 INC·Filed 2022·Granted Oct 14, 2025·0 cites·17 claims
- 0872US2020399345A1Methods of use of soluble cd24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2020·Application pending·0 cites
- 0963US2025043325A1Fucosidase mutants and the use thereofCHO PHARMA INC·Filed 2024·Application pending·0 cites
- 1062US2017233453A1Methods of use of soluble cd24 for therapy of rheumatoid arthritisONCOIMMUNE INC·Filed 2017·Application pending·0 cites
- 1162US2013231464A1Methods of use of soluble cd24 for therapy of rheumatoid arthritisONCOLMMUNE INC·Filed 2013·Application pending·0 cites
- 1258US2024183857A1Protein Tyrosine Phosphatases as Biomarkers for Hepatocellular Carcinoma and Uses ThereofUNIV BRUXELLES·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →